PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.
Also called NCT06915792
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 110 participants
- Registry
-
NCT06915792
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06915792. Randomized; no masking; primary purpose treatment. Start 2025-06-01 (actual); primary completion 2027-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
- Acronym
- PEACE
- Condition
- Postpartum Hypertension (PPHT)
- Intervention (Drug)
- Labetalol
- Intervention (Drug)
- Nifedipine
- Lead sponsor
- University of California, Los Angeles
Record details
- Record id
cardio:ct-nct06915792- Content hash
605af11a1395f842d7432465c142a57a6b7f0f2c0471618f3238dd785765fbb1